semaglutide for dementia Study finds Novo Nordisk's Ozempic may reduce A 2025 JAMA Network Open

The SURMOUNT-5 trial showed that maximum-dose tirzepatide produces about 47% more weight loss than maximum-dose semaglutide, so they are clearly not equivalent at their respective maximums

Retatrutide is still investigational and not widely approved for clinical use, whereas Tirzepatide is already approved and more widely accessible

Its cardiovascular benefit data established in the SELECT trial (2023), demonstrating a significant reduction in major cardiovascular events in adults with obesity without diabetes is more mature than tirzepatides cardiovascular outcomes data, which is accumulating but more recent

Pharmacies that pressure you to order large quantities upfront or lock you into long-term contracts deserve scrutiny

Convenient Dosing: Similar to Semaglutide, Tirzepatide is administered via a weekly injection, making it easy to fit into your routine without the need for daily medication